Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Diagnostic approach for genetic causes of intellectual disability

  • Yim, Shin-Young (The Children's Rehabilitation Clinic, Department of Physical Medicine and Rehabilitation, Department of Medical Genetics, Ajou University School of Medicine)
  • Received : 2014.12.01
  • Accepted : 2015.02.28
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Intellectual disability (ID) is the most common disability among people under the age of 20 years. In the absence of obvious non-genetic causes of ID, the majority of cases of severe ID are thought to have a genetic cause. The advent of technologies such as array comparative genomic hybridization, single nucleotide polymorphism genotyping arrays, and massively parallel sequencing has shown that de novo copy number variations and single nucleotide variations affecting coding regions are major causes of severe ID. This article reviews the genetic causes of ID along with diagnostic approaches for this disability.

Keywords

References

  1. American Association on Intellectual and Developmental Disabilities. Intellectual disability: definition, classification, and systems of supports. 11th ed. Washington, DC: AAIDD, 2010.
  2. Yim SY, Yu HH, Lee IY. The prevalence of mental retardation among third grade elementary school children in the Suwon area, Korea. J Korean Med Sci 2002;17:86-90. https://doi.org/10.3346/jkms.2002.17.1.86
  3. Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 2011;32:419-36. https://doi.org/10.1016/j.ridd.2010.12.018
  4. Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:57-9.
  5. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012;367:1921-9. https://doi.org/10.1056/NEJMoa1206524
  6. Bessa C, Lopes F, Maciel P. Molecular genetics of intellectual disability. In: Tan U, ed. Latest findings in intellectual and developmental disabilities research. Rijeka Croatia: InTech, 2012.
  7. Rajcan-Separovic E. Chromosome microarrays in human reproduction. Hum Reprod Update 2012;18:555-67. https://doi.org/10.1093/humupd/dms023
  8. Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 2005;6:782-92. https://doi.org/10.1038/nrg1692
  9. Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, Becker C, et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A 2006;140:2063-74.
  10. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010;61:437-55. https://doi.org/10.1146/annurev-med-100708-204735
  11. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010;466:368-72. https://doi.org/10.1038/nature09146
  12. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014;511:344-7. https://doi.org/10.1038/nature13394
  13. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21. https://doi.org/10.1126/science.1359641
  14. Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and autism. N Engl J Med 2012;366:733-43. https://doi.org/10.1056/NEJMra1114194
  15. Alkan C, Coe BP, Eichler EE. Genome structural variation discovery and genotyping. Nat Rev Genet 2011;12:363-76. https://doi.org/10.1038/nrg2958
  16. Manning M, Hudgins L; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010;12:742-5. https://doi.org/10.1097/GIM.0b013e3181f8baad
  17. Brady PD, Vermeesch JR. Genomic microarrays: a technology overview. Prenat Diagn 2012;32:336-43. https://doi.org/10.1002/pd.2933
  18. Hochstenbach R, Buizer-Voskamp JE, Vorstman JA, Ophoff RA. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. Cytogenet Genome Res 2011;135:174-202. https://doi.org/10.1159/000332928
  19. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838-46. https://doi.org/10.1038/ng.909
  20. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64. https://doi.org/10.1016/j.ajhg.2010.04.006
  21. Yim SY, Jeon BH, Yang JA, Kim HJ. Fragile X syndrome in Korea: a case series and a review of the literature. J Korean Med Sci 2008;23:470-6. https://doi.org/10.3346/jkms.2008.23.3.470
  22. Bedogni F, Rossi RL, Galli F, Cobolli Gigli C, Gandaglia A, Kilstrup-Nielsen C, et al. Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action. Neurosci Biobehav Rev 2014;46 Pt 2:187-201. https://doi.org/10.1016/j.neubiorev.2014.01.011
  23. Ng SB, Nickerson DA, Bamshad MJ, Shendure J. Massively parallel sequencing and rare disease. Hum Mol Genet 2010;19:R119-24. https://doi.org/10.1093/hmg/ddq390
  24. Jin HS, Lee JB, Kim K, Lee KY, Choi VN, Kim JS, et al. Identification of the rare compound heterozygous variants in the NEB gene in a Korean family with intellectual disability, epilepsy and early-childhood-onset generalized muscle weakness. J Hum Genet 2014;59:643-7. https://doi.org/10.1038/jhg.2014.87
  25. Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Gomez-Marin C, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 2014;507:371-5. https://doi.org/10.1038/nature13138
  26. Ayarpadikannan S, Kim HS. The impact of transposable elements in genome evolution and genetic instability and their implications in various diseases. Genomics Inform 2014;12:98-104. https://doi.org/10.5808/GI.2014.12.3.98